116 related articles for article (PubMed ID: 11801521)
1. Identifying the proportion of age related macular degeneration patients who would benefit from photodynamic therapy with verteporfin (Visudyne).
Mandal N; Chisholm IH
Br J Ophthalmol; 2002 Jan; 86(1):118-9. PubMed ID: 11801521
[No Abstract] [Full Text] [Related]
2. Photodynamic therapy with verteporfin (Visudyne) for macular degeneration.
Med Lett Drugs Ther; 2000 Sep; 42(1086):81-2. PubMed ID: 10980812
[No Abstract] [Full Text] [Related]
3. Photodynamic therapy for age-related macular degeneration.
Franks W
Age Ageing; 2002 Jan; 31(1):5-6. PubMed ID: 11850299
[No Abstract] [Full Text] [Related]
4. Photodynamic therapy in age-related macular degeneration: missing information.
Wenkstern A; Stokes J
Age Ageing; 2003 May; 32(3):357-9. PubMed ID: 12720631
[No Abstract] [Full Text] [Related]
5. Can [symbol: see text] verteporfin help in macular degeneration?
Drug Ther Bull; 2001 Apr; 39(4):30-2. PubMed ID: 11329798
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
7. [Photodynamic therapy with Vsudyne (Verteporfin)--an innovative therapy of age-related macular degeneration].
Augustin AJ
Krankenpfl J; 2000 Oct; 38(9-10):342-3. PubMed ID: 11194354
[No Abstract] [Full Text] [Related]
8. Verteporfin photodynamic therapy in the UK: implications of the NICE appraisal.
Harding S
Eye (Lond); 2003 Mar; 17(2):119-22. PubMed ID: 12640394
[No Abstract] [Full Text] [Related]
9. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
Hariprasad SM; Shah GK
Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
[TBL] [Abstract][Full Text] [Related]
10. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
[TBL] [Abstract][Full Text] [Related]
11. Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration.
Frennesson CI; Nilsson SE
Acta Ophthalmol Scand; 2004 Dec; 82(6):645-50. PubMed ID: 15606458
[TBL] [Abstract][Full Text] [Related]
12. Using light to treat age-related macular degeneration.
Nosek J
Nurs Times; 2005 Nov 15-21; 101(46):30-3. PubMed ID: 16315801
[TBL] [Abstract][Full Text] [Related]
13. Improvement after verteporfin therapy.
Anand R; Bressler NM; Bressler SB; Gray TE; Harvey P; Haynes L; Koester JM; Manos KS; Miller JW; Murphy S; Reaves A; Sickenberg M; Singerman LJ; Strong A; Stur M;
Arch Ophthalmol; 2003 Mar; 121(3):415-6. PubMed ID: 12617718
[No Abstract] [Full Text] [Related]
14. Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties.
Cruess AF; Zlateva G; Pleil AM; Wirostko B
Acta Ophthalmol; 2009 Mar; 87(2):118-32. PubMed ID: 18577193
[TBL] [Abstract][Full Text] [Related]
15. Ophthaproblem. Photodynamic therapy with verteporfin.
Sharma S
Can Fam Physician; 2001 May; 47():955, 963. PubMed ID: 11398726
[No Abstract] [Full Text] [Related]
16. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
Bressler NM;
Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
[TBL] [Abstract][Full Text] [Related]
17. Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
Brown DM; Kaiser PK; Michels M; Soubrane G; Heier JS; Kim RY; Sy JP; Schneider S;
N Engl J Med; 2006 Oct; 355(14):1432-44. PubMed ID: 17021319
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
Bressler NM; Bressler SB
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):624-8. PubMed ID: 10711673
[No Abstract] [Full Text] [Related]
19. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
[TBL] [Abstract][Full Text] [Related]
20. A preliminary benefit-risk assessment of verteporfin in age-related macular degeneration.
Wickens J; Blinder KJ
Drug Saf; 2006; 29(3):189-99. PubMed ID: 16524319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
